New England Asset Management Inc Viatris Inc Transaction History

New England Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$8.72 - $11.56 $5,162 - $6,843	-592 Reduced 75.8%	189 $2,000
Q3 2022 Nov 14, 2022	SELL	$8.48 - $11.13 $17,485 - $22,950	-2,062 Reduced 72.53%	781 $7,000
Q2 2021 Aug 16, 2021	SELL	$12.97 - $16.15 $3,787 - $4,715	-292 Reduced 9.31%	2,843 $41,000
Q1 2021 May 17, 2021	SELL	$13.59 - $18.54 $216,814 - $295,787	-15,954 Reduced 83.58%	3,135 $44,000
Q4 2020 Feb 16, 2021	BUY	$14.3 - $18.74 $272,972 - $357,727	19,089 New	19,089 $358,000

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.1B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of New England Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on New England Asset Management Inc with notifications on news.